Drug Shortage Report for VINCRISTINE SULFATE INJECTION
Report ID | 99955 |
Drug Identification Number | 02143305 |
Brand name | VINCRISTINE SULFATE INJECTION |
Common or Proper name | VINCRISTINE INJECTION 1MG/ML |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | VINCRISTINE SULFATE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 2ML |
ATC code | L01CA |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-11-28 |
Estimated end date | 2020-07-31 |
Actual end date | 2020-06-24 |
Shortage status | Resolved |
Updated date | 2020-06-25 |
Company comments | Allocating to 100% of our market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v18 | 2020-06-25 | French | Compare |
v17 | 2020-06-25 | English | Compare |
v16 | 2020-05-29 | French | Compare |
v15 | 2020-05-29 | English | Compare |
v14 | 2020-05-08 | French | Compare |
v13 | 2020-05-08 | English | Compare |
v12 | 2020-04-09 | French | Compare |
v11 | 2020-04-09 | English | Compare |
v10 | 2020-03-26 | French | Compare |
v9 | 2020-03-26 | English | Compare |
v8 | 2020-02-07 | French | Compare |
v7 | 2020-02-07 | English | Compare |
v6 | 2020-01-17 | French | Compare |
v5 | 2020-01-17 | English | Compare |
v4 | 2019-11-29 | English | Compare |
v3 | 2019-11-28 | French | Compare |
v2 | 2019-11-28 | English | Compare |
v1 | 2019-11-28 | English | Compare |
Showing 1 to 18 of 18